CHRU de Limoges - Hôpital Dupuytren

Limoges, Limousin 87042

0 studies enrolling now · 1 studies all time

What they study most

Non-small Cell Lung Cancer

Studies at this site

• TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy — Stopped early